Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of lacosamide in refractory focal epilepsy
ChiCTR2100051666Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lacosamide in epilepsy (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Seizure frequency. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2100051666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051666.